Related Experiment Videos
Hematoporphyrin phototherapy for experimental intraocular malignant melanoma
Abstract:
Administration of a hematoporphyrin derivative (HpD) followed by photoradiation with red light completely or partially destroyed Greene hamster melanoma developed in the anterior chamber of rabbit eyes. Tumor-bearing eyes were divided into two groups. Twenty-two eyes received an HpD injection followed by exposure to red light from a slide projector with a 500-W quartz halogen lamp and a red filter (intensity to the tumor was about 4.0 mW/sq cm). In the control group (six eyes), eyes were exposed either to red light only or to HpD injection only. Local complications after therapy included edema and congestion of the conjunctiva, clouding of the cornea, and hemorrhage on the iris surface. The HpD itself has no cytotoxic effect, is preferentially retained in tumor cells, and causes a destructive photodynamic effect as a result of the production of cytotoxic singlet oxygen in the tumor. Accordingly, it may be a safe and potentially therapeutic procedure in the treatment of uveal melanoma.
Insights
Hematoporphyrin derivative (HpD) photodynamic therapy effectively treated Greene hamster melanoma in rabbit eyes. This cancer treatment utilizes red light and HpD for a destructive photodynamic effect, showing potential for uveal melanoma.
Area of Science:
- Ophthalmology
- Oncology
- Photochemistry
Background:
- Uveal melanoma is a significant intraocular malignancy.
- Current treatment options for uveal melanoma have limitations.
- Hematoporphyrin derivative (HpD) is a photosensitizing agent.
Purpose of the Study:
- To evaluate the efficacy of HpD-based photodynamic therapy (PDT) in treating experimental anterior chamber melanoma in rabbits.
- To assess the safety and potential therapeutic application of this PDT approach for uveal melanoma.
Main Methods:
- Greene hamster melanoma was induced in the anterior chamber of rabbit eyes.
- Tumor-bearing eyes received an injection of hematoporphyrin derivative (HpD).
- Eyes were subsequently exposed to red light (4.0 mW/sq cm) to activate the HpD, with control groups receiving only red light or HpD.
Main Results:
- Photodynamic therapy with HpD and red light resulted in complete or partial destruction of the melanoma.
- Local complications observed included conjunctival edema, corneal clouding, and iris hemorrhage.
- HpD demonstrated preferential retention in tumor cells and induced a photodynamic effect via singlet oxygen production.
Conclusions:
- HpD-mediated photodynamic therapy is a potentially effective treatment for experimental ocular melanoma.
- The mechanism involves HpD's photosensitizing properties and singlet oxygen generation.
- This approach may offer a safe and therapeutic option for human uveal melanoma treatment.